Circulation, Vol 66, 342-354, Copyright © 1982 by American Heart Association
SM Factor, T Minase, S Cho, R Dominitz and EH Sonnenblick
The cardiomyopathic Syrian hamster develops focal myocardial necrosis
beginning at 1 month of age, which leads to eventual ventricular failure
within 1 year. The pathogenesis of this myocytolytic necrosis is unknown.
Based on the nature of the cell necrosis, cytochemical evidence of vascular
alterations, and the sensitivity of the hamsters to catecholamines and
other vasoactive substances, we believe that the cardiomyopathy may be
mediated by abnormalities of the microcirculation. Nonetheless, until the
present study, no significant changes have been observed in these vessels.
To elucidate the pathogenesis of this disease, we perfused living
cardiomyopathic hamsters with silicone rubber solutions, which revealed
numerous areas of microvascular constriction, diffuse vessel narrowing and
luminal irregularity. Fixed structural lesions in these vessels could not
be demonstrated. Pretreatment of young hamsters with verapamil during the
period when they normally develop myocardial necrosis prevented
myocytolytic lesions and abolished microvascular hyperreactivity. We
believe that focal, transient spasm of small blood vessels, probably
secondary to vasoactive substances, may cause myocytolytic necrosis (a form
of reperfusion injury) in this model. This may also be a multifactorial
disease with myocellular as well as vascular abnormalities leading to
myocardial degeneration. The similarity of this disease to human and
experimental cardiomyopathy suggests that microvascular spasm may be a
common denominator of many different cardiomyopathic syndromes.
ARTICLES
Microvascular spasm in the cardiomyopathic Syrian hamster: a preventable cause of focal myocardial necrosis
This article has been cited by other articles:
 |
|
 |
|
  L. Lipskaia, C. Pinet, Y. Fromes, S. Hatem, I. Cantaloube, A. Coulombe, and A.-M. Lompre Mutation of {delta}-Sarcoglycan Is Associated with Ca2+-Dependent Vascular Remodeling in the Syrian Hamster Am. J. Pathol., July 1, 2007; 171(1): 162 - 171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Komamura, R. Tatsumi, J.-i. Miyazaki, K. Matsumoto, E. Yamato, T. Nakamura, Y. Shimizu, T. Nakatani, S. Kitamura, H. Tomoike, et al. Treatment of Dilated Cardiomyopathy With Electroporation of Hepatocyte Growth Factor Gene Into Skeletal Muscle Hypertension, September 1, 2004; 44(3): 365 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Wheeler, C. E. Korcarz, K. A. Collins, K. A. Lapidos, A. A. Hack, M. R. Lyons, S. Zarnegar, J. U. Earley, R. M. Lang, and E. M. McNally Secondary Coronary Artery Vasospasm Promotes Cardiomyopathy Progression Am. J. Pathol., March 1, 2004; 164(3): 1063 - 1071. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Brutsaert Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac Growth, Contractile Performance, and Rhythmicity Physiol Rev, January 1, 2003; 83(1): 59 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Woodman, D. S. Park, A. W. Cohen, M. W.-C. Cheung, M. Chandra, J. Shirani, B. Tang, L. A. Jelicks, R. N. Kitsis, G. J. Christ, et al. Caveolin-3 Knock-out Mice Develop a Progressive Cardiomyopathy and Show Hyperactivation of the p42/44 MAPK Cascade J. Biol. Chem., October 4, 2002; 277(41): 38988 - 38997. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Kay, P. Yue, Z. Hanna, S. Jothy, E. Tremblay, and P. Jolicoeur Cardiac Disease in Transgenic Mice Expressing Human Immunodeficiency Virus-1 Nef in Cells of the Immune System Am. J. Pathol., July 1, 2002; 161(1): 321 - 335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ikeda, Y. Gu, Y. Iwanaga, M. Hoshijima, S. S. Oh, F. J. Giordano, J. Chen, V. Nigro, K. L. Peterson, K. R. Chien, et al. Restoration of Deficient Membrane Proteins in the Cardiomyopathic Hamster by In Vivo Cardiac Gene Transfer Circulation, January 29, 2002; 105(4): 502 - 508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.T. WHEELER, M.J. ALLIKIAN, A. HEYDEMANN, and E.M. MCNALLY The Sarcoglycan Complex in Striated and Vascular Smooth Muscle Cold Spring Harb Symp Quant Biol, January 1, 2002; 67(0): 389 - 398. [Abstract] [PDF]
|
|
|
|
|
|
S.M. DALLABRIDA and M.A. RUPNICK Vascular Endothelium in Tissue Remodeling: Implications for Heart Failure Cold Spring Harb Symp Quant Biol, January 1, 2002; 67(0): 417 - 428. [Abstract] [PDF]
|
|
|
|
 |
|
 E. P. Moiseeva Adhesion receptors of vascular smooth muscle cells and their functions Cardiovasc Res, December 1, 2001; 52(3): 372 - 386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-i. Saitoh, F. Onogi, K. Aikawa, M. Muto, T. Saito, K. Maehara, and Y. Maruyama Multiple endothelial injury in epicardial coronary artery induces downstream microvascular spasm as well as remodeling partly via thromboxane A2 J. Am. Coll. Cardiol., January 1, 2001; 37(1): 308 - 315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. Clark and L. C. Fuchs BKCa channels compensate for loss of NOS-dependent coronary artery relaxation in cardiomyopathy Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2598 - H2603. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ikeda, M. Martone, Y. Gu, M. Hoshijima, A. Thor, S. S. Oh, K. L. Peterson, and J. Ross Jr. Altered membrane proteins and permeability correlate with cardiac dysfunction in cardiomyopathic hamsters Am J Physiol Heart Circ Physiol, April 1, 2000; 278(4): H1362 - H1370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Straub, A. J. Ettinger, M. Durbeej, D. P. Venzke, S. Cutshall, J. R. Sanes, and K. P. Campbell epsilon -Sarcoglycan Replaces alpha -Sarcoglycan in Smooth Muscle to Form a Unique Dystrophin-Glycoprotein Complex J. Biol. Chem., September 24, 1999; 274(39): 27989 - 27996. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kumamoto, H. Okamoto, M. Watanabe, H. Onozuka, K. Yoneya, I. Nakagawa, S. Chiba, S. Watanabe, T. Mikami, K. Abe, et al. Beneficial effect of myocardial angiogenesis on cardiac remodeling process by amlodipine and MCI-154 Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1117 - H1123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Mathier, G. A. Rose, M. A. Fifer, M. I. Miyamoto, R. E. Dinsmore, H. H. Castano, G. W. Dec, I. F. Palacios, and M. J. Semigran Coronary endothelial dysfunction in patients with acute-onset idiopathic dilated cardiomyopathy J. Am. Coll. Cardiol., July 1, 1998; 32(1): 216 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Okada, J. Woodcock-Mitchell, J. Mitchell, T. Sakamoto, K. Marutsuka, B. E. Sobel, and S. Fujii Induction of Plasminogen Activator Inhibitor Type 1 and Type 1 Collagen Expression in Rat Cardiac Microvascular Endothelial Cells by Interleukin-1 and Its Dependence on Oxygen-Centered Free Radicals Circulation, June 2, 1998; 97(21): 2175 - 2182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Li, Q. Li, X. Wang, K. P. Jana, G. Redaelli, J. Kajstura, and P. Anversa Coronary constriction impairs cardiac function and induces myocardial damage and ventricular remodeling in mice Am J Physiol Heart Circ Physiol, November 1, 1997; 273(5): H2508 - H2519. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Watanabe, H. Kusuoka, K. Fukuchi, T. Fujiwara, and T. Nishimura Contribution of hypoxia to the development of cardiomyopathy in hamsters Cardiovasc Res, August 1, 1997; 35(2): 217 - 222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kajstura, X. Zhang, Y. Liu, E. Szoke, W. Cheng, G. Olivetti, T. H. Hintze, and P. Anversa The Cellular Basis of Pacing-Induced Dilated Cardiomyopathy : Myocyte Cell Loss and Myocyte Cellular Reactive Hypertrophy Circulation, October 15, 1995; 92(8): 2306 - 2317. [Abstract] [Full Text]
|
|
|
|
|
|
D. Neglia, O. Parodi, M. Gallopin, G. Sambuceti, A. Giorgetti, L. Pratali, P. Salvadori, C. Michelassi, M. Lunardi, G. Pelosi, et al. Myocardial Blood Flow Response to Pacing Tachycardia and to Dipyridamole Infusion in Patients With Dilated Cardiomyopathy Without Overt Heart Failure : A Quantitative Assessment by Positron Emission Tomography Circulation, August 15, 1995; 92(4): 796 - 804. [Abstract] [Full Text]
|
|
|
|
 |
|
 Drugs Five Years Later: Nifedipine in Myocardial Ischemia, Systemic Hypertension, and Other Cardiovascular Disorders Ann Intern Med, November 1, 1986; 105(5): 714 - 729. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Wagner, I. Reynolds, H. Weisman, P Dudeck, M. Weisfeldt, and S. Snyder Calcium antagonist receptors in cardiomyopathic hamster: selective increases in heart, muscle, brain Science, April 25, 1986; 232(4749): 515 - 518. [Abstract] [PDF]
|
|